Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia
about
Spanning the genomics era: the vital role of a single institution biorepository for childhood cancer research over a decadeEviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia.Abnormally high expression of POLD1, MCM2, and PLK4 promotes relapse of acute lymphoblastic leukemia.
P2860
Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia
description
im Februar 2013 veröffentlicher wissenschaftlicher Artikel
@de
scientific article published on 20 February 2013
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2013
@uk
name
Fat1 cadherin provides a novel ...... n acute lymphoblastic leukemia
@en
Fat1 cadherin provides a novel ...... n acute lymphoblastic leukemia
@nl
type
label
Fat1 cadherin provides a novel ...... n acute lymphoblastic leukemia
@en
Fat1 cadherin provides a novel ...... n acute lymphoblastic leukemia
@nl
prefLabel
Fat1 cadherin provides a novel ...... n acute lymphoblastic leukemia
@en
Fat1 cadherin provides a novel ...... n acute lymphoblastic leukemia
@nl
P2093
P2860
P50
P1433
P1476
Fat1 cadherin provides a novel ...... n acute lymphoblastic leukemia
@en
P2093
Andrew W Boyd
Gordon F Burns
Rick F Thorne
P2860
P304
P356
10.1179/1607845413Y.0000000080
P577
2013-02-20T00:00:00Z